GlassScriptPhysician profile
Jimin Hwang
NPI 1053088617
$2,095.39
in general payments reported to CMS, 2019-2025
17 companies · $644 in 2025
The $644 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $250 · 2023: $624 · 2024: $578 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,645 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,645.19 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $279.24 | 2023-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $256.50 | 2025 | Lumryz |
| Jazz Pharmaceuticals INC. | $201.94 | 2022-2023 | |
| Abbvie INC. | $185.50 | 2022-2025 | |
| Inspire Medical Systems, INC. | $133.72 | 2024 | Inspire |
| Neurelis, INC. | $124.99 | 2023 | Valtoco |
| Biohaven Pharmaceutical Holding Company LTD. | $121.52 | 2022 | |
| Azurity Pharmaceuticals, INC. | $107.57 | 2023 | Horizant |
| Biogen, INC. | $97.47 | 2023 | Tysabri |
| Merz North America, INC. | $92.86 | 2024 | |
| Tg Therapeutics, INC. | $92.29 | 2025 | |
| Genentech USA, INC. | $88.94 | 2025 | Ocrevus |
| Sk Life Science, INC. | $84.99 | 2024 | Xcopri |
| Lilly USA, LLC | $81.36 | 2024 | Zepbound |
| Ucb, INC. | $75.24 | 2024 | Fintepla |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $55.03 | 2023 | Wakix |
| Axsome Therapeutics, INC. | $16.23 | 2023 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimin Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.